Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5114/ceji.2014.42132 http://scihub22266oqcxt.onion/10.5114/ceji.2014.42132 C4439976!4439976!26155107     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cent+Eur+J+Immunol 2014 ; 39 (1): 96-9 Nephropedia Template TP {{tp|p=26155107|t=2014. Serial ImmuKnow assay in stable kidney transplant recipients |pdf=|usr=}}{{26155107}} gab.com Text Serial ImmuKnow assay in stable kidney transplant recipients JO: Cent Eur J Immunol http://www.kidney.de/pget.php?&tw=1&pmid=26155107 #FOAvip Objectives: The ImmuKnow assay (cylex Inc., Columbia, MD) has been reported to measure the global immune monitoring tool for organ transplantation recipients. We assess immuKnow ATP values in stable kidney transplant patients. Material and methods: Patients who were kidney transplanted between September 2008 and May 2011 were enrolled in the prospective serial ImmuKnow assay study. The criteria of inclusion were living donor kidney transplantation (KT), no evidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, and PRA less than 50%. ImmuKnow assay monitoring was performed at one day before operation, post operative weeks 4, 8, 12, 16, 20, 24, 36 and 52. We excluded patients who had undergone infectious syndrome or rejection episodes during the follow-up period. Results: Among 71 patients who were enrolled in prospective serial ImmuKnow assay monitoring, 37 patients were proven to stable KT patients during the follow-up period. Two hundred and twenty-four samples from 37 patients were collected. ImmuKnow value and immunosuppression drug level were compared in post operative weeks 4, 8, 12, 16, 20, 24, 36 and 52. The value of ImmuKnow assay was significantly different depending on the length of time after transplant (p = 0.038). Interestingly, the pre-transplant ImmuKnow values were lower than those of the immediate post-transplant period. Conclusions: The ImmuKnow value of stable KT recipients is different according to ?time after transplant?. Therefore, ?time after transplant? should be considered when applying an ImmuKnow assay in clinical practice. Twit Text FOAVip Serial ImmuKnow assay in stable kidney transplant recipients ????Cent Eur J Immunol http://www.kidney.de/pget.php?&tw=1&pmid=26155107 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26155107 #FOAvip English Wikipedia <ref>{{Cite pmid|26155107}}</ref> Serial ImmuKnow assay in stable kidney transplant recipients #MMPMID26155107 Moon HH; Kim Ts; Lee S; Song S; Shin M; Park JB; Kim JM; Jang HR; Huh W; Joh JW; Kim SJ Cent Eur J Immunol 2014[]; 39 (1): 96-9 PMID26155107show ga Objectives: The ImmuKnow assay (cylex Inc., Columbia, MD) has been reported to measure the global immune monitoring tool for organ transplantation recipients. We assess immuKnow ATP values in stable kidney transplant patients. Material and methods: Patients who were kidney transplanted between September 2008 and May 2011 were enrolled in the prospective serial ImmuKnow assay study. The criteria of inclusion were living donor kidney transplantation (KT), no evidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, and PRA less than 50%. ImmuKnow assay monitoring was performed at one day before operation, post operative weeks 4, 8, 12, 16, 20, 24, 36 and 52. We excluded patients who had undergone infectious syndrome or rejection episodes during the follow-up period. Results: Among 71 patients who were enrolled in prospective serial ImmuKnow assay monitoring, 37 patients were proven to stable KT patients during the follow-up period. Two hundred and twenty-four samples from 37 patients were collected. ImmuKnow value and immunosuppression drug level were compared in post operative weeks 4, 8, 12, 16, 20, 24, 36 and 52. The value of ImmuKnow assay was significantly different depending on the length of time after transplant (p = 0.038). Interestingly, the pre-transplant ImmuKnow values were lower than those of the immediate post-transplant period. Conclusions: The ImmuKnow value of stable KT recipients is different according to ?time after transplant?. Therefore, ?time after transplant? should be considered when applying an ImmuKnow assay in clinical practice. äSerial ImmuKnow assay in stable kidney transplant recipients (epmc).pdf DeepDyve Pubget Overpricing